BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 30554718)

  • 21. Safety of Ultrasound-Guided Botulinum Toxin Injections for Sialorrhea as Performed by Pediatric Otolaryngologists.
    Shariat-Madar B; Chun RH; Sulman CG; Conley SF
    Otolaryngol Head Neck Surg; 2016 May; 154(5):924-7. PubMed ID: 26908558
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Managing children with sialorrhoea (drooling): Experience from the first 301 children in our saliva control clinic.
    Montgomery J; McCusker S; Lang K; Grosse S; Mace A; Lumley R; Kubba H
    Int J Pediatr Otorhinolaryngol; 2016 Jun; 85():33-9. PubMed ID: 27240493
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction.
    Gubbay A; Marie Blackmore A
    Int J Pediatr Otorhinolaryngol; 2019 Sep; 124():124-128. PubMed ID: 31185343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ten years of experience with intravesical and intrasphincteric onabotulinumtoxinA in children.
    Greer T; Abbott J; Breytenbach W; McGuane D; Barker A; Khosa J; Samnakay N
    J Pediatr Urol; 2016 Apr; 12(2):94.e1-6. PubMed ID: 26472538
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Botulinum Toxin A and B in sialorrhea: Long-term data and literature overview.
    Petracca M; Guidubaldi A; Ricciardi L; Ialongo T; Del Grande A; Mulas D; Di Stasio E; Bentivoglio AR
    Toxicon; 2015 Dec; 107(Pt A):129-40. PubMed ID: 26327120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Onabotulinum toxin A for the treatment of sialorrhea in familial dysautonomia.
    Daniel SJ; Cardona I
    Int J Pediatr Otorhinolaryngol; 2014 May; 78(5):879-81. PubMed ID: 24725647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical study of botulinum-A toxin in the treatment of sialorrhea in children with cerebral palsy.
    Suskind DL; Tilton A
    Laryngoscope; 2002 Jan; 112(1):73-81. PubMed ID: 11802042
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salivary gland ablation: introducing an interventional radiology treatment alternative in the management of sialorrhea.
    Begley KA; Braswell LE; Noritz GH; Murakami JW
    Pediatr Radiol; 2020 May; 50(6):869-876. PubMed ID: 32198665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of onabotulinum toxin A treatment with salivary pH and dental caries of neurologically impaired children with sialorrhea.
    Ferraz Dos Santos B; Dabbagh B; Daniel SJ; Schwartz S
    Int J Paediatr Dent; 2016 Jan; 26(1):45-51. PubMed ID: 25726732
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Botox(®) to reduce drooling in a paediatric population with neurological impairments: a Phase I study.
    Hay N; Penn C
    Int J Lang Commun Disord; 2011; 46(5):550-63. PubMed ID: 21899672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-to-date report of botulinum toxin therapy in patients with drooling caused by different etiologies.
    Ellies M; Laskawi R; Rohrbach-Volland S; Arglebe C
    J Oral Maxillofac Surg; 2003 Apr; 61(4):454-7. PubMed ID: 12684962
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Case Report of Systemic Intoxication Following Onabotulinum Toxin A Injections Into the Salivary Glands in a Patient With Spinal Muscular Atrophy Type 1.
    Kim DH; Elsherbini N; Zielinski D; Oskoui M
    Pediatr Neurol; 2022 Apr; 129():37-38. PubMed ID: 35217275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial.
    Isaacson SH; Ondo W; Jackson CE; Trosch RM; Molho E; Pagan F; Lew M; Dashtipour K; Clinch T; Espay AJ;
    JAMA Neurol; 2020 Apr; 77(4):461-469. PubMed ID: 31930364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Botulinum Toxin in Functional Hypersalivation--All about Dosage?].
    Steffen A; Hasselbacher K; Brüggemann N; Heinrichs S; Schönweiler R; Wollenberg B
    Laryngorhinootologie; 2015 Jun; 94(6):378-82. PubMed ID: 25437838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ultrasound-guided botulinum toxin injections for treatment of drooling.
    Breheret R; Bizon A; Jeufroy C; Laccourreye L
    Eur Ann Otorhinolaryngol Head Neck Dis; 2011 Nov; 128(5):224-9. PubMed ID: 21600865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tolerance of salivary gland botulinum toxin A injection under local anesthesia for the treatment of sialorrhea in children: An observational study.
    Toulemonde P; Maltezeanu A; Broucqsault H; Fayoux P
    Eur Ann Otorhinolaryngol Head Neck Dis; 2022 Mar; 139(2):77-81. PubMed ID: 34217684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Interests of the ultrasound-guidance in the treatment of drooling through botulinum toxin injections, our experience over 10 years].
    Mailly M; Rebours C; Koskas P; Klap P; Ayache D; Cohen M
    J Stomatol Oral Maxillofac Surg; 2017 Feb; 118(1):5-10. PubMed ID: 28330576
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cumulative Efficacy of Longitudinal Repeat Salivary Gland OnabotulinumtoxinA Injection: A Retrospective Study.
    Shoval H; Friel K; Levin J; Kim H
    Am J Phys Med Rehabil; 2021 Aug; 100(8):798-802. PubMed ID: 33394592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Botulinum toxin A for treatment of sialorrhea in children: an effective, minimally invasive approach.
    Khan WU; Campisi P; Nadarajah S; Shakur YA; Khan N; Semenuk D; McCann C; Roske L; McConney-Ellis S; Joseph M; Parra D; Amaral J; John P; Temple M; Connolly B
    Arch Otolaryngol Head Neck Surg; 2011 Apr; 137(4):339-44. PubMed ID: 21242533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A review of options for treating sialorrhea in amyotrophic lateral sclerosis.
    Banfi P; Ticozzi N; Lax A; Guidugli GA; Nicolini A; Silani V
    Respir Care; 2015 Mar; 60(3):446-54. PubMed ID: 25228780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.